Grand Rounds: Drug Resistant Epilepsy, moving beyond medications
10-31-2025
By Lucyna Zawadzki, MD, Chinasa Nwankwo, MD, and Gwyneth Hughes, MD, , Pediatric Epilepsy Program, Akron Children's
More about Chinasa Nwankwo, MD
More about Gwyneth Hughes, MD
More about Lucyna Zawadzki, MD
Objectives (Educational Content) :
1. Review the definition and prevalence of drug-resistant epilepsy.
2. Learn non-medication treatment options, including dietary and surgical options.
3. Analyze neuromodulation as a newer treatment option for intractable epilepsy.
Target Audience:
General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists, and nurses.
Identified Gap:
Increase awareness of epilepsy surgery for treatment of refractory epilepsy and promote visibility of the outstanding epilepsy care we provide to our patients.
Estimated Time to Complete the Educational Activity:
1 hour(s)
Expiration Date for CE/CME Credit:
10-30-2026
Method of Participation in the Learning Process:
The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.
Evaluation Methods:
All learners must successfully complete a post-test, as well as an activity evaluation, to claim CE/CME credit.
Disclosure:
The speaker(s) has returned the disclosure form, indicating that the following financial relationships with ineligible companies: Livanova - Chinasa Nwankwo, MD All financial relationships have been mitigated. The speaker(s) has returned the disclosure form, indicating that there are no financial relationships with ineligible companies: Gwyneth Hughes, MD Lucyna Zawadzki, MD The following CME Committee/Planning Committee member(s) has the following financial relationships with ineligible companies to disclose: Merck - Maria Cristina Victorio, MD Moderna, Pfizer and Merck - Shefali Mahesh, MD All financial relationships have been mitigated.
Accreditation Statement:
Children’s Hospital Medical Center of Akron is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.
CHMCA designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Bibliography:
1. https://www.akronchildrens.org/inside/2025/10/21/responsive-neurostimulator-rns-technology-changes-conners-life/
2. Heck et al., Epilepsia 2014 and Nair et al., Neurology 2020
3. Razavi and Rao, et al., 2020

